France's Cellectis wins US patents for gene editing technology – Reuters

France's Cellectis wins US patents for gene editing technology
Reuters
“These inventions are based on the early work initiated by inventors at Cellectis when the CRISPR technology first came to light,” the company said. CRISPR, an abbreviation of Clustered Regularly Interspaced Short Palindromic Repeats, forms the basis

Read more: www.reuters.com

Leave a Reply

Your email address will not be published. Required fields are marked *